Protagonist Therapeutics, Inc

PTGXNASDAQ • USD
130.95 USD
↘ 3.43 (2.55%)AT CLOSE (03:59 PM EST)
130.90
↘ 0.05 (0.04%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
130.90
↘ 0.05 (0.04%)
🔴Market: CLOSED

Shares of Protagonist Therapeutics, Inc (PTGX) are trading at $130.95. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, exceptional Return on Equity (31.6%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$134.03
High?$134.90
Low?$130.64
Prev. Close?$134.38
Volume?759.9K
Avg. Volume?698.7K
VWAP?$132.19
Rel. Volume?1.09x
Bid / Ask
Bid?$130.00 × 100
Ask?$165.00 × 200
Spread?$35.00
Midpoint?$147.50
Valuation & Ratios
Market Cap?8.5B
Shares Out?65.3M
Float?61.2M
Float %?94.6%
P/E Ratio?24.97
P/B Ratio?7.88
EPS?$5.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Employees
141
Market Cap
8.5B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-08-11
Address
7707 GATEWAY BLVD., SUITE 140
NEWARK, CA 94560-1160
Phone: (510) 474-0170
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
100
Momentum?
97
Short Sent.?
39
Piotroski F-Score?4/9Mixed
Altman Z-Score?85.60Safe
Confidence?62%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?16.73%High
Short Interest?10.2M
Days to Cover?16.9
Free Float61.2M
Avg Daily Volume606.3K
Settlement Date2026-10-30
Financial Health
Current Ratio?19.85Strong
Quick Ratio?19.85Strong
Cash Ratio?8.98Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
47/100
P/E?
Peers
100
S&P
48
25.0FAIR▾
P/B?
Peers
100
S&P
24
7.88FAIR▾
P/S?
Peers
100
S&P
3
15.49HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
16
24.8HIGH▾
EV/Sales?
Peers
100
S&P
3
14.59HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
80
31.6%STRONG▾
ROA?
Peers
50
S&P
97
29.8%STRONG▾
Cash Flow & Enterprise
FCF?$-111760000
Enterprise Value?$8.0B
Fundamentals ratios updated end of day